Inventor · disambiguated record
Ronald Charles Hawley
Also filed as: HAWLEY RONALD · HAWLEY RONALD C · HAWLEY RONALD CHARLES
58 granted patents·32 pending applications·426 citations·filing 1994–2024
98Inventor score
Files withROCHE PALO ALTO LLC38SYNTEX INC8AFFERENT PHARMACEUTICALS INC7RIBOSCIENCE LLC6SAVIRA PHARMACEUTICALS GMBH5
Top patents by PatentIndex Score
90 records- 0195US7858632B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2005·Granted Dec 28, 2010·28 cites·30 claims
- 0293US8008313B2Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2006·Granted Aug 30, 2011·20 cites·13 claims
- 0392US2025066309A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2024·Application pending·0 cites
- 0490US8846705B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsBROKA CHRIS ALLEN·Filed 2010·Granted Sep 30, 2014·11 cites·24 claims
- 0589US5493030A5-substituted derivatives of mycophenolic acidSYNTEX INC·Filed 1994·Granted Feb 20, 1996·64 cites·3 claims
- 0689US2025025462A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2024·Application pending·0 cites
- 0788US8524725B2Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modulators for treatment of respiratory and gastrointestinal diseasesBROKA CHRIS ALLEN·Filed 2011·Granted Sep 3, 2013·9 cites·13 claims
- 0887US7595405B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2007·Granted Sep 29, 2009·7 cites·30 claims
- 0987US2024158356A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2023·Application pending·0 cites
- 1086US8318719B2Inhibitors of Bruton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2010·Granted Nov 27, 2012·12 cites·37 claims
- 1186US5444072A6-substituted mycophenolic acid and derivativesSYNTEX INC·Filed 1994·Granted Aug 22, 1995·56 cites·28 claims
- 1285US5633279A5-substituted derivatives of mycophenolic acidSYNTEX INC·Filed 1995·Granted May 27, 1997·64 cites·44 claims
- 1383US10822311B2Pyrimidines and variants thereof, and uses thereforAFFERENT PHARMACEUTICALS INC·Filed 2017·Granted Nov 3, 2020·3 cites·16 claims
- 1482US8048905B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2008·Granted Nov 1, 2011·4 cites·16 claims
- 1582US6524808B1Enzyme inhibition immunoassayROCHE DIAGNOSTICS CORP·Filed 2000·Granted Feb 25, 2003·21 cites·21 claims
- 1682US2023100975A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2022·Application pending·0 cites
- 1781US10662162B2Pyrimidines and variants thereof, and uses thereforAFFERENT PHARMACEUTICALS INC·Filed 2017·Granted May 26, 2020·2 cites·8 claims
- 1881US8841336B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2011·Granted Sep 23, 2014·4 cites·17 claims
- 1981US7786110B2Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2007·Granted Aug 31, 2010·5 cites·16 claims
- 2081US6846834B2Antiinflammation agentsAMGEN INC·Filed 2001·Granted Jan 25, 2005·15 cites·73 claims
- 2179US10676444B2Crystalline salts and polymorphs of a P2X3 antagonistAFFERENT PHARMACEUTICALS INC·Filed 2017·Granted Jun 9, 2020·1 cites·20 claims
- 2279US7186841B2Antiinflammation agentsSYNTEX LLC·Filed 2004·Granted Mar 6, 2007·11 cites·4 claims
- 2378US8193368B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsDILLON MICHAEL PATRICK·Filed 2009·Granted Jun 5, 2012·2 cites·34 claims
- 2477US9556127B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2014·Granted Jan 31, 2017·1 cites·9 claims
- 2575US7285561B2Imidazo-substituted compounds as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Oct 23, 2007·1 cites·10 claims
- 2675US7081462B2Imidazo-substituted compounds as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2005·Granted Jul 25, 2006·1 cites·11 claims
- 2775US2021009531A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2020·Application pending·0 cites
- 2874US9505726B2Substituted biphenyl amides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2014·Granted Nov 29, 2016·1 cites·18 claims
- 2974US6846828B2Aminopyrimidine and aminopyridine anti-inflammation agentsROCHE PALO ALTO LLC·Filed 2002·Granted Jan 25, 2005·6 cites·51 claims
- 3074US6811998B2Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenaseROCHE DIAGNOSTICS OPERATIONS·Filed 2003·Granted Nov 2, 2004·8 cites·8 claims
- 3174US2021008071A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2020·Application pending·0 cites
- 3273US2020115347A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2019·Application pending·0 cites
- 3372US2025041319A1Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 3472US2019270713A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2019·Application pending·0 cites
- 3571US8501933B2Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2010·Granted Aug 6, 2013·1 cites·32 claims
- 3671US8440708B2Triazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2011·Granted May 14, 2013·1 cites·28 claims
- 3771US6949560B2Imidazo-substituted compounds as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2003·Granted Sep 27, 2005·3 cites·21 claims
- 3870US2019016688A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2018·Application pending·0 cites
- 3969US2025320204A17-aza bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 4068US2018141919A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2017·Application pending·0 cites
- 4167US7157580B2Aminopyrimidine and aminopyridine anti-inflammation agentsROCHE PALO ALTO LLC·Filed 2004·Granted Jan 2, 2007·2 cites·2 claims
- 4266US11230533B2Crystalline salts and polymorphs of a P2X3 antagonistAFFERENT PHARMACEUTICALS INC·Filed 2020·Granted Jan 25, 2022·0 cites·19 claims
- 4366US2018311240A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2018·Application pending·0 cites
- 4465US2017096404A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2016·Application pending·0 cites
- 4564US11591315B2Substituted pyrazole-pyrimidines, variants thereof, and uses thereforeAFFERENT PHARMACEUTICALS INC·Filed 2021·Granted Feb 28, 2023·0 cites·12 claims
- 4664US8440673B2Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2008·Granted May 14, 2013·0 cites·15 claims
- 4764US7235675B2Conjugates of mycophenolic acidROCHE DIAGNOSTICS OPERATIONS·Filed 2004·Granted Jun 26, 2007·2 cites·10 claims
- 4863US12029744B2Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2020·Granted Jul 9, 2024·0 cites·40 claims
- 4963US7989637B2Triazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2008·Granted Aug 2, 2011·0 cites·10 claims
- 5063US7476727B2Conjugates of mycophenolic acidROCHE DIAGNOSTICS OPERATIONS·Filed 2007·Granted Jan 13, 2009·0 cites·1 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →